Update
$PDS Biotechnology(PDSB.US$ PDS Biotech Announces Interim Safety and Immune Response Data From Phase 1/2 Clinical Trial Evaluating Novel Antibody Drug Conjugate PDS0301 Combined With Docetaxel to Treat Metastatic Prostate Cancer
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment